CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
1,228,431
Share change
+163,457
Total reported value
$14,725,999
Price per share
$11.99
Number of holders
33
Value change
+$1,899,325
Number of buys
23
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q2 2016

As of 30 Jun 2016, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,228,431 shares. The largest 10 holders included BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Investment Management, LLC, Bank of New York Mellon Corp, TIAA CREF INVESTMENT MANAGEMENT LLC, and Zurcher Kantonalbank (Zurich Cantonalbank). This page lists 33 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.